Evidence map›Paper›PMID 20953328›Full record

ArticleMediators of inflammation2010

12/15-lipoxygenase is an interleukin-13 and interferon-γ counterregulated-mediator of allergic airway inflammation.

Alexa R Lindley, Margaret Crapster-Pregont, Yanjun Liu, Douglas A Kuperman

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Crafting Molecular Tools for 15-Lipoxygenase-1 in a Single Step.Angewandte Chemie (International ed. in English) · 2025
    Article
  2. Hematopoietic 12/15-lipoxygenase activity negatively contributes to fungal-associated allergic asthma.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  3. Review
  4. Article
  5. Observational
  6. Review
  7. Predictive significance of arachidonate 15-lipoxygenase for eosinophilic chronic rhinosinusitis with nasal polyps.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2020
    Article
  8. Article
  9. Article
  10. The nasal methylome and childhood atopic asthma.The Journal of allergy and clinical immunology · 2017
    Article
  11. Article
  12. Activity-Based Probes for 15-Lipoxygenase-1.Angewandte Chemie (International ed. in English) · 2016
    Article
  13. Article
  14. Article
  15. Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alexa R LindleyAllergy-Immunology Division, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Margaret Crapster-Pregont
Yanjun Liu
Douglas A Kuperman
Northwestern University · US

Funding

15-lipoxygenase regulation of mucosal immunity in allergic airways diseaseR01AI076315 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KUPERMAN, DOUGLAS A · 2008 to 2011
$1.5M
Arachidonic Acid Mediated Regulation of Secretory IgA Levels in the AirwaysR21AI083534 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KUPERMAN, DOUGLAS A · 2009 to 2010
$419k
NIAID NIH HHS AI076315NIAID NIH HHS AI083534NIAID NIH HHS R01 AI076315NIAID NIH HHS R21 AI083534
6 · The paper itself

Abstract

Interleukin-13 and interferon-γ are important effectors of T-helper cells. Interleukin-13 increases expression of the arachidonic acid-metabolizing enzyme, 15-lipoxygenase-1, in a variety of cell types. 15-lipoxygenase-1 is dramatically elevated in the airways of subjects with asthma. Studies in animals indicate that 15-lipoxygenase-1 contributes to the development of allergic airway inflammation but is protective in some other forms of inflammation. We tested the hypothesis that the ability of interleukin-13 and interferon-γ to counterregulate allergic airway inflammation was potentially mediated by counterregulation of 12/15-lipoxygenase, the mouse ortholog of 15-lipoxygenase-1. The airways of mice were treated with interleukin-13 or interferon-γ one day prior to each of the four allergen exposures. Interleukin-13 augmented and interferon-γ inhibited allergic airway inflammation independently of systemic IgE and mucosal IgA responses but in association with counterregulation of 12/15-lipoxygenase. Interleukin-13 and interferon-γ counterregulate 12/15-lipoxygenase potentially contributing to the effects of these cytokines on allergic airway inflammation.

Indexed as

Gene Expression RegulationAllergensAnimalsArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseAsthmaCytokinesHumansHypersensitivityImmunoglobulin AImmunoglobulin EInflammationInterferon-gammaInterleukin-13MiceMice, Inbred C57BL12-15-lipoxygenaseAllergensArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseCytokinesImmunoglobulin AImmunoglobulin EInterferon-gammaInterleukin-13

Identifiers

PMID20953328
PMCPMC2952968
OpenAlexW2004245851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.